POLR3A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.517200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.725000E-01
Normal-vs-Stage2
7.848400E-01
Normal-vs-Stage3
5.514000E-02
Normal-vs-Stage4
7.422600E-01
Stage1-vs-Stage2
5.639600E-01
Stage1-vs-Stage3
2.047900E-02
Stage1-vs-Stage4
7.368400E-01
Stage2-vs-Stage3
9.735800E-02
Stage2-vs-Stage4
3.706800E-01
Stage3-vs-Stage4
1.125560E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.701800E-01
Normal-vs-AfricanAmerican
7.686000E-01
Normal-vs-Asian
3.284000E-01
Caucasian-vs-AfricanAmerican
5.406200E-01
Caucasian-vs-Asian
2.199200E-01
AfricanAmerican-vs-Asian
1.158370E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.520800E-01
Normal-vs-Female
9.472600E-01
Male-vs-Female
4.733400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.109200E-01
Normal-vs-Age(41-60Yrs)
9.320400E-01
Normal-vs-Age(61-80Yrs)
8.098400E-01
Normal-vs-Age(81-100Yrs)
4.690200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.987600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.733600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.506400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.080600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.314780E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.223200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.243000E-01
Normal-vs-Daily Drinker
4.544000E-01
Normal-vs-Weekly Drinker
9.297000E-01
Normal-vs-Occasional Drinker
7.174200E-01
Normal-vs-Social Drinker
7.810200E-01
Non Drinker-vs-Daily Drinker
8.991400E-01
Non Drinker-vs-Weekly Drinker
2.767400E-01
Non Drinker-vs-Occasional Drinker
5.677600E-02
Non Drinker-vs-Social Drinker
2.391800E-02
Daily Drinker-vs-Weekly Drinker
3.193200E-01
Daily Drinker-vs-Occasional Drinker
7.852300E-02
Daily Drinker-vs-Social Drinker
6.996200E-02
Weekly Drinker-vs-Occasional Drinker
6.714000E-01
Weekly Drinker-vs-Social Drinker
8.834800E-01
Occasional Drinker-vs-Social Drinker
7.158200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.764000E-01
Normal-vs-Grade 2
1.252580E-01
Normal-vs-Grade 3
4.088300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.846800E-01
Grade 1-vs-Grade 3
8.280000E-01
Grade 1-vs-Grade 4
2.764000E-01
Grade 2-vs-Grade 3
5.404200E-01
Grade 2-vs-Grade 4
1.252580E-01
Grade 3-vs-Grade 4
4.088300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.506800E-01
Normal-vs-NonDiabetic
8.039000E-01
Diabetic-vs-NonDiabetic
4.319800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.337600E-01
Normal-vs-NoPancreatitis
8.072200E-01
Pancreatitis-vs-NoPancreatitis
4.454200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.446800E-01
Normal-vs-N1
7.982600E-01
N0-vs-N1
5.782200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.996000E-01
Normal-vs-TP53-NonMutant
8.291600E-01
TP53-Mutant-vs-TP53-NonMutant
7.105000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
